José Carlos Burmester Palomino

Executive with over 30 years of experience in pharmaceutical business development across Latin America. Founder of Latin Pharma, President of APROCIF and CEO of SEMAFAR. Specialized in international expansion, strategic partnerships, market intelligence and End-to-End commercial execution, connecting Latin American companies with partners across Asia, Europe and North America.

Founder and CEO of SEMAFAR, a company specialized in designing, implementing and operating End-to-End commercial solutions for the pharmaceutical industry. We deliver market intelligence, commercial execution, outsourcing, medical promotion and retail pharmacy projects across Central America, the Caribbean, Colombia and Peru.

Founder and President of APROCIF, an independent organization dedicated to strengthening the pharmaceutical industry through networking, executive education, international collaboration and business development initiatives across Latin America.

Led the commercial development of pharmaceutical sales audit and market intelligence solutions across Central America and the Caribbean. Managed strategic partnerships with pharmaceutical companies, driving regional business growth and strengthening Business Intelligence for commercial decision-making.

Led commercial strategy and business development for the pharmaceutical division across Latin America. Responsible for regional expansion, P&L management, distributor development and strategic partnerships in Central America, the Caribbean, Colombia and Ecuador.

Led the regional integration of ASTA Médica following its acquisition by Grupo CHEMO, driving Exeltis’ commercial and organizational transformation across Central America and the Caribbean. Responsible for regional P&L, business development, commercial strategy, distributor management and multicultural teams, achieving sustained double-digit growth in sales, market share and prescription rankings.

Led the establishment of Siegfried Peru, a Roemmers Group subsidiary, building the operation from the ground up following the acquisition of IQF’s pharmaceutical portfolio. Responsible for legal incorporation, organizational setup, regulatory strategy, commercial development, sales force implementation and portfolio launch, successfully positioning the company in the Peruvian market.

Hired to lead Refasa/Carrión’s business transformation prior to its acquisition by Eurofarma Group. Responsible for commercial growth, organizational restructuring, Marketing Department creation, institutional business development and strategic planning, increasing the company’s value and ensuring a successful corporate integration.

Led Tecnofarma Colombia’s commercial and organizational transformation. Directed the reengineering of Sales, Marketing and Human Resources, implementing performance KPIs, sales force development programs and commercial excellence models. Achieved the company’s highest institutional oncology business growth through strategic product launches and high-performance commercial initiatives.

Led the establishment of Asofarma Dominican Republic (now Adium) as an independent operation within the Tecnofarma Group. Responsible for financial, administrative, regulatory and commercial operations, building the organization, sales force and corporate culture from the ground up. Successfully led the company’s largest portfolio expansion and product launch program in the country.

Led Tecnofarma Peru’s commercial and marketing strategy, driving portfolio growth, promotional investment and business development. Created Tec-Salud, an innovative physician and patient engagement program that, due to its success, was adopted and implemented across Tecnofarma’s subsidiaries throughout Latin America.